Resverlogix Corp. (TSE:RVX – Get Free Report) passed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$0.11 and traded as low as C$0.11. Resverlogix shares last traded at C$0.11, with a volume of 100,700 shares trading hands.
Resverlogix Price Performance
The company has a quick ratio of 0.04, a current ratio of 0.05 and a debt-to-equity ratio of -15.77. The firm’s fifty day moving average price is C$0.11 and its two-hundred day moving average price is C$0.10. The stock has a market capitalization of C$31.61 million, a PE ratio of -3.67 and a beta of 0.73.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Articles
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
